Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax.

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: on behalf of the government of the United States of America, as represented by the Secretary of the Army, AY is listed as inventor on issued and accepted patents on VMP001 and CSV-S,S. These did not influence the study design, conduct, or data analysis. NCW declares no conflict. This does not alter our adherence to all PLOS policies on sharing data and materials.